Average Co-Inventor Count = 5.56
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (26 from 3,684 patents)
2. Bristol-myers Squibb Pharma Company (6 from 234 patents)
3. The Dupont Merck Pharmaceutical Company (6 from 206 patents)
4. Dupont Pharmaceuticals Company (3 from 106 patents)
5. Bristol-myers Squibb (1 from 36 patents)
6. Dupont Pharmaceuticals, Inc. (1 from 15 patents)
43 patents:
1. 12428421 - Pyrimidinones as factor XIA inhibitors
2. 11306081 - Phenylacetamides as inhibitors of rock
3. 11053247 - Pyrimidinones as factor XIA inhibitors
4. 10829501 - Spiroheptane salicylamides and related compounds as inhibitors of ROCK
5. 10676477 - Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group
6. 10611776 - Spiroheptane salicylamides and related compounds as inhibitors of rock
7. 10336754 - Pyrimidinones as factor XIa inhibitors
8. 10273236 - Macrocyclic factor XIa inhibitors bearing heterocyclic groups
9. 10208021 - Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
10. 10000466 - Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitors
11. 9944625 - Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors
12. 9777001 - Macrocycles with aromatic P2' groups as factor xia inhibitors
13. 9738655 - Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors
14. 9725435 - Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitors
15. 9453018 - Pyrimidinones as factor XIa inhibitors